CN100396330C - 修复神经损伤及促进神经功能复元之组合物及方法 - Google Patents
修复神经损伤及促进神经功能复元之组合物及方法 Download PDFInfo
- Publication number
- CN100396330C CN100396330C CNB200510109130XA CN200510109130A CN100396330C CN 100396330 C CN100396330 C CN 100396330C CN B200510109130X A CNB200510109130X A CN B200510109130XA CN 200510109130 A CN200510109130 A CN 200510109130A CN 100396330 C CN100396330 C CN 100396330C
- Authority
- CN
- China
- Prior art keywords
- nerve
- gdnf
- group
- fibrin glue
- repairing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/484—Plasmin (3.4.21.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/106—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Surgery (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Inorganic Chemistry (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (3)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/967,907 | 2004-10-18 | ||
US10/967,907 US20060083734A1 (en) | 2004-10-18 | 2004-10-18 | Composition and method for repairing nerve damage and enhancing functional recovery of nerve |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1768858A CN1768858A (zh) | 2006-05-10 |
CN100396330C true CN100396330C (zh) | 2008-06-25 |
Family
ID=35545754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200510109130XA Expired - Fee Related CN100396330C (zh) | 2004-10-18 | 2005-10-18 | 修复神经损伤及促进神经功能复元之组合物及方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20060083734A1 (zh) |
EP (1) | EP1650224B1 (zh) |
JP (1) | JP2006117668A (zh) |
CN (1) | CN100396330C (zh) |
TW (1) | TWI357335B (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080107632A1 (en) * | 2006-09-06 | 2008-05-08 | Henrich Cheng | Fibrin glue composition for repairing nerve damage and methods thereof |
WO2008036294A2 (en) * | 2006-09-19 | 2008-03-27 | Northwestern University | Nos inhibitors for treatment of motor deficit disorders |
EP2148634A1 (en) * | 2007-05-15 | 2010-02-03 | Axongen Ab | Fibrin-based nerve repair conduit and method of producing the same |
EP2271312A4 (en) * | 2008-03-19 | 2013-12-11 | Univ Florida | NERVOUS REPAIR WITH A HYDROGEL AND AN OPTIONAL ADHESIVE |
CA2736230C (en) * | 2008-09-04 | 2021-06-29 | Abt Holding Company | Use of stem cells to prevent neuronal dieback |
CN101897960B (zh) * | 2010-04-14 | 2012-09-12 | 中国人民解放军第三军医大学野战外科研究所 | 促进脊髓神经再生与功能恢复的hNgR-Fc融合蛋白疫苗 |
US8758374B2 (en) | 2010-09-15 | 2014-06-24 | University Of Utah Research Foundation | Method for connecting nerves via a side-to-side epineurial window using artificial conduits |
JP6154135B2 (ja) * | 2010-12-03 | 2017-06-28 | 国立大学法人 岡山大学 | 外傷性神経障害治療剤 |
US10842494B2 (en) | 2011-10-17 | 2020-11-24 | University Of Utah Research Foundation | Methods and devices for connecting nerves |
US9931121B2 (en) | 2011-10-17 | 2018-04-03 | University Of Utah Research Foundation | Methods and devices for connecting nerves |
CN112386681A (zh) * | 2012-01-27 | 2021-02-23 | 桑比欧公司 | 用于调节血管生成和血管发生的方法和组合物 |
US20140155816A1 (en) * | 2012-10-09 | 2014-06-05 | Eu Sol Biotech Co., Ltd. | Method for treating brain injury or stroke |
CN112138143A (zh) * | 2019-06-26 | 2020-12-29 | 杭州生物医药创新研究中心 | 一种用于治疗神经损伤疾病的药物组合物 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1144693A (zh) * | 1996-08-08 | 1997-03-12 | 陈素兰 | 神经损伤修复制剂 |
CN1203531A (zh) * | 1995-11-29 | 1998-12-30 | 安姆根有限公司 | 用胶质细胞系衍生神经营养因子(gdnf)蛋白产物治疗视网膜神经节细胞损伤的方法 |
WO2003077917A1 (en) * | 2002-03-14 | 2003-09-25 | Children's Medical Center Corporation | Axon regeneration with pkc inhibitiors |
US20040138155A1 (en) * | 1994-03-15 | 2004-07-15 | Selective Genetics, Inc. | Devices containing DNA encoding neurotrophic agents and related compositions and methods |
US20040267289A1 (en) * | 2003-01-29 | 2004-12-30 | Henrich Cheng | Method and mixture for nerve root repair |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6921532B1 (en) * | 2000-06-22 | 2005-07-26 | Spinal Restoration, Inc. | Biological Bioadhesive composition and methods of preparation and use |
US20050118156A1 (en) * | 2001-12-04 | 2005-06-02 | Woolverton Christopher J. | Storage-stable fibrin sealant |
-
2004
- 2004-10-18 US US10/967,907 patent/US20060083734A1/en not_active Abandoned
-
2005
- 2005-10-14 TW TW094135857A patent/TWI357335B/zh not_active IP Right Cessation
- 2005-10-18 JP JP2005302957A patent/JP2006117668A/ja active Pending
- 2005-10-18 CN CNB200510109130XA patent/CN100396330C/zh not_active Expired - Fee Related
- 2005-10-18 EP EP05256462A patent/EP1650224B1/en not_active Not-in-force
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040138155A1 (en) * | 1994-03-15 | 2004-07-15 | Selective Genetics, Inc. | Devices containing DNA encoding neurotrophic agents and related compositions and methods |
CN1203531A (zh) * | 1995-11-29 | 1998-12-30 | 安姆根有限公司 | 用胶质细胞系衍生神经营养因子(gdnf)蛋白产物治疗视网膜神经节细胞损伤的方法 |
CN1144693A (zh) * | 1996-08-08 | 1997-03-12 | 陈素兰 | 神经损伤修复制剂 |
WO2003077917A1 (en) * | 2002-03-14 | 2003-09-25 | Children's Medical Center Corporation | Axon regeneration with pkc inhibitiors |
US20040267289A1 (en) * | 2003-01-29 | 2004-12-30 | Henrich Cheng | Method and mixture for nerve root repair |
Non-Patent Citations (8)
Title |
---|
CHARACTERIZATION OF A FIBRIN GLUE-GDNFSLOW-RELEASE PREPARATION. CHENG H et al.Cell Transplantation,Vol.vol.7 No.no.1. 1998 |
CHARACTERIZATION OF A FIBRIN GLUE-GDNFSLOW-RELEASE PREPARATION. CHENG H et al.Cell Transplantation,Vol.vol.7 No.no.1. 1998 * |
GDNF的研究进展. 袁源等.神经解剖学杂志,第19卷第1期. 2003 |
GDNF的研究进展. 袁源等.神经解剖学杂志,第19卷第1期. 2003 * |
Repair of peripheral nerve transections with fibrin sealantcontaining neurotrophic factors. Jubran M et al.Experimental Neurology,Vol.vol.181 . 2003 |
Repair of peripheral nerve transections with fibrin sealantcontaining neurotrophic factors. Jubran M et al.Experimental Neurology,Vol.vol.181 . 2003 * |
Spinal Cord Repair With Acidic Fibroblast Growth Factor as aTreatment for a Patient With Chronic Paraplegia. Cheng H et al.Spine,Vol.vol.29 No.no.14. 2004 |
Spinal Cord Repair With Acidic Fibroblast Growth Factor as aTreatment for a Patient With Chronic Paraplegia. Cheng H et al.Spine,Vol.vol.29 No.no.14. 2004 * |
Also Published As
Publication number | Publication date |
---|---|
EP1650224B1 (en) | 2013-03-06 |
TWI357335B (en) | 2012-02-01 |
CN1768858A (zh) | 2006-05-10 |
JP2006117668A (ja) | 2006-05-11 |
TW200626169A (en) | 2006-08-01 |
EP1650224A1 (en) | 2006-04-26 |
US20060083734A1 (en) | 2006-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100396330C (zh) | 修复神经损伤及促进神经功能复元之组合物及方法 | |
DE69831589T2 (de) | Zusammenfügung von knorpelmatrizen unter verwendung isolierter chondrozyten | |
Chuah et al. | Olfactory ensheathing cells promote collateral axonal branching in the injured adult rat spinal cord | |
Cohen et al. | Expression of agrin in the developing and adult rat brain | |
Lee et al. | Motor recovery and anatomical evidence of axonal regrowth in spinal cord-repaired adult rats | |
Alvites et al. | Combined use of chitosan and olfactory mucosa mesenchymal stem/stromal cells to promote peripheral nerve regeneration in vivo | |
CN106511971A (zh) | 神经调节蛋白在治疗外周神经损伤中的应用 | |
Cheng et al. | The neuroprotective effect of glial cell line-derived neurotrophic factor in fibrin glue against chronic focal cerebral ischemia in conscious rats | |
Reyes et al. | Promoting neurological recovery following a traumatic peripheral nerve injury. | |
CN104870043A (zh) | 用于治疗脑损伤或中风的试剂盒 | |
Burggasser et al. | The temporalis: blood supply and innervation | |
Cupido et al. | Surgical procedures to study microglial motility in the brain and in the spinal cord by in vivo two-photon laser-scanning microscopy | |
Ceber et al. | The relationship between changes in the expression of growth associated protein–43 and functional recovery of the injured inferior alveolar nerve following transection without repair in adult rats | |
Hayakawa et al. | Facial nerve regeneration with bioabsorbable collagen conduits filled with collagen filaments: An experimental study | |
Tang et al. | Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats | |
Vares et al. | Effects of platelet-rich fibrin/collagen membrane on sciatic nerve regeneration | |
Chamorro et al. | The effect of omental wrapping on nerve graft regeneration | |
Stauber et al. | Comparative morphology of muscle-skeleton attachments in the Echinodermata | |
Niimi et al. | Effectively axonal-supercharged interpositional jump-graft with an artificial nerve conduit for rat facial nerve paralysis | |
CN101138630A (zh) | 用于修复神经损伤的纤维蛋白胶组合物及其方法 | |
Chen et al. | Optimizing conditions and avoiding pitfalls for prolonged axonal tracing with carbocyanine dyes in fixed rat spinal cords | |
Holmberg et al. | Secondary brain injuries in thalamus and hippocampus after focal ischemia caused by mild, transient extradural compression of the somatosensori cortex in the rat | |
Barski et al. | Autologous connective tissue bars as vehicles for the administration of growth-influencing substances to the brain | |
Marks et al. | A minimally invasive thrombotic stroke model to study circadian rhythm in awake mice | |
KR20210157764A (ko) | 뇌손상 치료물질이 비강 내로 이식된 동물 모델 및 이의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TAIBEI RONGMIN GENERAL HOSPITAL Free format text: FORMER OWNER: ZHENG HONGZHI Effective date: 20130118 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130118 Address after: China Taiwan Taipei City Beitou District Shipai road two No. 201 Patentee after: Taipei Veterans General Hospital Address before: China Taiwan Taipei City Beitou District Shipai road two No. 322 Patentee before: Zheng Hongzhi |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080625 Termination date: 20191018 |
|
CF01 | Termination of patent right due to non-payment of annual fee |